These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9563397)

  • 1. Aprotinin versus lysine analogues: the debate continues.
    Royston D
    Ann Thorac Surg; 1998 Apr; 65(4 Suppl):S9-19; discussion S27-8. PubMed ID: 9563397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
    Cochrane Database Syst Rev; 2011 Jan; (1):CD001886. PubMed ID: 21249650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; McClelland B; Laupacis A; Fergusson D
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001886. PubMed ID: 17943760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD001886. PubMed ID: 21412876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis.
    Henry D; Carless P; Fergusson D; Laupacis A
    CMAJ; 2009 Jan; 180(2):183-93. PubMed ID: 19050037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    Fergusson DA; Hébert PC; Mazer CD; Fremes S; MacAdams C; Murkin JM; Teoh K; Duke PC; Arellano R; Blajchman MA; Bussières JS; Côté D; Karski J; Martineau R; Robblee JA; Rodger M; Wells G; Clinch J; Pretorius R;
    N Engl J Med; 2008 May; 358(22):2319-31. PubMed ID: 18480196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators.
    Laupacis A; Fergusson D
    Anesth Analg; 1997 Dec; 85(6):1258-67. PubMed ID: 9390590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
    Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
    J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
    Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
    Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost/benefit analysis of pharmacologic hemostasis.
    Harmon DE
    Ann Thorac Surg; 1996 Feb; 61(2 Suppl):S21-5; discussion S33-4. PubMed ID: 8572828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery.
    Ide M; Bolliger D; Taketomi T; Tanaka KA
    J Anesth; 2010 Feb; 24(1):96-106. PubMed ID: 20039075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aprotinin in cardiac surgery: more risks than usefulness?].
    Bremerich DH; Strametz R; Kirchner R; Moritz A; Zwissler B
    Anaesthesist; 2006 Sep; 55(9):989-92, 994-6. PubMed ID: 16874472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemostasis and antifibrinolytic therapy in major pediatric surgery].
    Schindler E; Hertfelder HJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Jul; 48(7-8):454-61; quiz 462. PubMed ID: 23929163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery.
    Casati V; Guzzon D; Oppizzi M; Cossolini M; Torri G; Calori G; Alfieri O
    Ann Thorac Surg; 1999 Dec; 68(6):2252-6; discussion 2256-7. PubMed ID: 10617012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial.
    Bennett-Guerrero E; Sorohan JG; Gurevich ML; Kazanjian PE; Levy RR; Barberá AV; White WD; Slaughter TF; Sladen RN; Smith PK; Newman MF
    Anesthesiology; 1997 Dec; 87(6):1373-80. PubMed ID: 9416723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin and tranexamic acid for high transfusion risk cardiac surgery.
    Wong BI; McLean RF; Fremes SE; Deemar KA; Harrington EM; Christakis GT; Goldman BS
    Ann Thorac Surg; 2000 Mar; 69(3):808-16. PubMed ID: 10750765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.